Identifying modifiable risk factors for mortality in children aged 1–59 months admitted with WHO-defined severe pneumonia: a single-centre observational cohort study from rural Malawi
Main Authors: | Mina C Hosseinipour, Eric D McCollum, Tisungane Mvalo, Davie Kondowe, Michelle Eckerle, Andrew G Smith, Dhananjay Vaidya, Don Makonokaya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-04-01
|
Series: | BMJ Paediatrics Open |
Online Access: | https://bmjpaedsopen.bmj.com/content/6/1/e001330.full |
Similar Items
-
Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis.
by: Tisungane Mvalo, et al.
Published: (2022-01-01) -
Bubble CPAP and oxygen for child pneumonia care in Malawi: a CPAP IMPACT time motion study
by: Kristen L. Sessions, et al.
Published: (2019-07-01) -
Haemophilus influenzae type b and pneumococcal conjugate vaccination coverage in children aged 2-59 months in Malawi
by: Daphne Gadama, et al.
Published: (2021-02-01) -
Title Correction: Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study “Innovative Treatments in Pneumonia”
by: Ginsburg, Amy Sarah, et al.
Published: (2019-08-01) -
Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis.
by: Eric D McCollum, et al.
Published: (2019-01-01)